Evidence map›Paper›PMID 35919990›Full record

ArticleCancer research2022

Orthovoltage X-Rays Exhibit Increased Efficacy Compared with γ-Rays in Preclinical Irradiation.

Brett I Bell, Justin Vercellino, N Patrik Brodin, Christian Velten, Lalitha S Y Nanduri, Prashanth K B Nagesh, Kathryn E Tanaka, Yanan Fang, Yanhua Wang, Rodney Macedo and 11 more

Abstract read
In one paragraph

Article in Cancer research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Whole Abdominal Pencil Beam Scanned Proton FLASH Increases Acute Lethality.International journal of radiation oncology, biology, physics · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Radiation-induced multi-organ injury.International journal of radiation biology · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Brett I BellDepartment of Radiation Oncology, Montefiore Medical Center, Bronx, New York.ORCID 0000-0002-8439-1402
Justin VercellinoDepartment of Radiation Oncology, Montefiore Medical Center, Bronx, New York.ORCID 0000-0002-8286-4376
N Patrik BrodinDepartment of Radiation Oncology, Montefiore Medical Center, Bronx, New York.ORCID 0000-0003-1061-0841
Christian VeltenDepartment of Radiation Oncology, Montefiore Medical Center, Bronx, New York.ORCID 0000-0001-9621-588X
Lalitha S Y NanduriDepartment of Radiation Oncology, Montefiore Medical Center, Bronx, New York.ORCID 0000-0002-9776-3439
Prashanth K B NageshLaboratory of Signal Transduction, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0003-3518-405X
Kathryn E TanakaDepartment of Pathology, Albert Einstein College of Medicine, Bronx, New York.ORCID 0000-0002-9016-1937
Yanan FangDepartment of Pathology, Albert Einstein College of Medicine, Bronx, New York.ORCID 0000-0002-1112-9569
Yanhua WangDepartment of Pathology, Albert Einstein College of Medicine, Bronx, New York.ORCID 0000-0002-7946-2843
Rodney MacedoDepartment of Radiation Oncology, Montefiore Medical Center, Bronx, New York.ORCID 0000-0001-6252-7703
Jeb EnglishDepartment of Radiation Oncology, Montefiore Medical Center, Bronx, New York.ORCID 0000-0001-5610-4317
Michelle M SchumacherDepartment of Radiation Oncology, Montefiore Medical Center, Bronx, New York.ORCID 0000-0003-1313-0501
Phaneendra K DuddempudiDepartment of Biochemistry, Albert Einstein College of Medicine, Bronx, New York.ORCID 0000-0002-2625-8179
Patrik AspDepartment of Radiation Oncology, Montefiore Medical Center, Bronx, New York.ORCID 0000-0003-0816-4854
Wade KobaDepartment of Radiology, Albert Einstein College of Medicine, Bronx, New York.ORCID 0000-0002-6015-8382
Shahin ShajahanDepartment of Radiation Oncology, Montefiore Medical Center, Bronx, New York.ORCID 0000-0001-5350-8965
Laibin LiuDepartment of Radiation Oncology, Montefiore Medical Center, Bronx, New York.ORCID 0000-0002-5759-5282
Wolfgang A ToméDepartment of Radiation Oncology, Montefiore Medical Center, Bronx, New York.ORCID 0000-0003-1586-8091
Weng-Lang YangDepartment of Radiation Oncology, Montefiore Medical Center, Bronx, New York.ORCID 0000-0001-6128-6557
Richard KolesnickLaboratory of Signal Transduction, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0002-4914-2945
Chandan GuhaDepartment of Radiation Oncology, Montefiore Medical Center, Bronx, New York.ORCID 0000-0002-1906-2186

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI STEVEN C. ALMO · 1985 to 2026
$111.2M
Intestinal Stem Cell Consortium Coordinating CenterU01DK085532 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI NILAND, JOYCE CAROL · 2009 to 2018
$6.5M
Understanding stem cell heterogeneity and niche function in intestinal regeneration after irradiationU01DK103155 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GUHA, CHANDAN, WANG, TIMOTHY CRAGIN · 2014 to 2023
$4.4M
Dissecting anti-ceramide scFv vascular mitigation of the Radiation GI SyndromeU01AI133598 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI KOLESNICK, RICHARD N · 2017 to 2021
$3.1M
Stromal cell therapy as a treatment against Gastrointestinal Acute Radiation Syndrome (GI-ARS)U01AI138324 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI GUHA, CHANDAN · 2018 to 2022
$2.9M
Novel Strategies for Precision T-cell TherapiesR01CA198095 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ALMO, STEVEN C. · 2016 to 2020
$2.8M
Relative Immunological Effectiveness (RIE) of Carbon Ion Radiation Therapy for Pancreatic CancerR01CA257509 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI GUHA, CHANDAN · 2021 to 2025
$2.5M
Development of thrombopoietin mimetic (TPOm) as a mitigator against Radiation-induced endovascular injuriesU01AI133608 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI GHOSH, SANCHITA P, GUHA, CHANDAN · 2017 to 2021
$2.4M
Limited Competition for the Continuation of the Intestinal Stem Cell Consortium Coordinating CenterU24DK085532 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI NILAND, JOYCE CAROL · 2019 to 2023
$2.3M
Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell toleranceR01CA226861 · NCI · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI GUHA, CHANDAN, MACIAN, FERNANDO · 2018 to 2022
$1.9M
Optimizing resilience assays for biology of aging research in miceR01AG057429 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI HUFFMAN, DEREK MAJOR · 2017 to 2021
$1.8M
NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA013330NCI NIH HHS R01 CA198095NCI NIH HHS R01 CA226861NCI NIH HHS R01 CA257509NIAID NIH HHS U01 AI133598NIAID NIH HHS U01 AI133608NIAID NIH HHS U01 AI138324NIA NIH HHS R01 AG057429NIDDK NIH HHS U01 DK085532NIDDK NIH HHS U01 DK103155NIDDK NIH HHS U24 DK085532NIH HHS S10 OD019961NIH HHS S10 OD026833NIH HHS S10 OD026852
6 · The paper itself

Abstract

Radionuclide irradiators (137Cs and 60Co) are commonly used in preclinical studies ranging from cancer therapy to stem cell biology. Amidst concerns of radiological terrorism, there are institutional initiatives to replace radionuclide sources with lower energy X-ray sources. As researchers transition, questions remain regarding whether the biological effects of γ-rays may be recapitulated with orthovoltage X-rays because different energies may induce divergent biological effects. We therefore sought to compare the effects of orthovoltage X-rays with 1-mm Cu or Thoraeus filtration and 137Cs γ-rays using mouse models of acute radiation syndrome. Following whole-body irradiation, 30-day overall survival was assessed, and the lethal dose to provoke 50% mortality within 30-days (LD50) was calculated by logistic regression. LD50 doses were 6.7 Gy, 7.4 Gy, and 8.1 Gy with 1-mm Cu-filtered X-rays, Thoraeus-filtered X-rays, and 137Cs γ-rays, respectively. Comparison of bone marrow, spleen, and intestinal tissue from mice irradiated with equivalent doses indicated that injury was most severe with 1-mm Cu-filtered X-rays, which resulted in the greatest reduction in bone marrow cellularity, hematopoietic stem and progenitor populations, intestinal crypts, and OLFM4+ intestinal stem cells. Thoraeus-filtered X-rays provoked an intermediate phenotype, with 137Cs showing the least damage. This study reveals a dichotomy between physical dose and biological effect as researchers transition to orthovoltage X-rays. With decreasing energy, there is increasing hematopoietic and intestinal injury, necessitating dose reduction to achieve comparable biological effects. SIGNIFICANCE: Understanding the significance of physical dose delivered using energetically different methods of radiation treatment will aid the transition from radionuclide γ-irradiators to orthovoltage X-irradiators.

Indexed as

Cesium RadioisotopesWhole-Body IrradiationAnimalsGamma RaysMiceX-RaysCesium-137Cesium Radioisotopes

Identifiers

PMID35919990
PMCPMC9354647

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.